- cross-posted to:
- [email protected]
- [email protected]
- cross-posted to:
- [email protected]
- [email protected]
23andMe’s fall from $6 billion to nearly $0 — a valuation collapse of 98% from its peak in 2021::undefined
23andMe’s fall from $6 billion to nearly $0 — a valuation collapse of 98% from its peak in 2021::undefined
https://archive.is/20240131113900/https://www.wsj.com/health/healthcare/23andme-anne-wojcicki-healthcare-stock-913468f4
Here’s an archived copy of the page.